The role of screening and monitoring for bleomycin pulmonary toxicity

Bleomycin-induced pulmonary toxicity can have a significant impact on patient outcomes. However, no guidelines for ideal screening and monitoring are available. This paper reviews the literature to identify the best way to monitor and reduce patient risk for bleomycin pulmonary toxicity. We have created evidence-based guidelines to help healthcare professionals identify patient risk factors and provide appropriate assessment and monitoring for patients receiving bleomycin therapy.
Source: Journal of Oncology Pharmacy Practice - Category: Cancer & Oncology Authors: Tags: Review Articles Source Type: research